Compare GNTA & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNTA | HHS |
|---|---|---|
| Founded | 2014 | 1923 |
| Country | Italy | United States |
| Employees | 13 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 21.2M |
| IPO Year | N/A | 1994 |
| Metric | GNTA | HHS |
|---|---|---|
| Price | $0.68 | $2.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 65.7K | 3.8K |
| Earning Date | 03-24-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $159,570,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.59 | $2.22 |
| 52 Week High | $10.00 | $5.39 |
| Indicator | GNTA | HHS |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 38.18 |
| Support Level | $0.60 | $2.28 |
| Resistance Level | $0.91 | $3.03 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 21.78 | 37.97 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.